HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
AML Progress in 2021 and a Look to the Future with Dr. Eytan Stein
AML Progress in 2021 and a Look to the Future with Dr. Eytan Stein	 image
HealthTree Podcast for AML
event Feb 02, 2022 / 12:00PM - 01:00PM EST

Event Description

There is a tremendous amount of progress being made in AML. It was remarkable to see the significant work being done in the field of AML at the recent American Society of Hematology (ASH) conference in Atlanta in December 2021. 

AML expert and Director of the Program for Drug Development in Leukemia at Memorial Sloan Kettering, Dr. Eytan Stein, will share the top AML research of 2021 that was presented by himself and his colleagues at the 2021 ASH conference. He will cover a breadth of topics such as treatment options in the newly diagnosed and relapsed setting, what's been learned about maintenance therapy and MRD status, how COVID-19 is affecting AML patients and the advancements of various immunotherapies. Dr. Stein will summarize topics to consider at each phase of AML in a clear and concise way. He will end by providing us his thoughts on what AML advancements and research to look out for in 2022.  

Schedule & Agenda

Katie Braswell
Welcome, announcements and introduction
Dr. Eytan Stein
Dr. Eytan Stein will summarize his top AML abstracts and research projects that were presented at the 2021 American Society of Hematology conference and provide us his thoughts on what AML advancements to look out for in 2022.
Question and Answer Session
Audience is able to call in to the radio show (515) 602-9728 to ask Dr. Stein questions about what was discussed during our interview today.

Speakers & Moderators

The panelist Katie Braswell
Katie Braswell
Dallas, Texas

Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors and travel to new places.

Read Bio
The panelist Eytan Stein, MD
Eytan Stein, MD
New York, New York

Hematologist Oncologist, Director of the Program for Drug Development in Leukemia at MSKCC

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us


(800) 930-5159


Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Astellas Pharma

Follow Us

facebook instagram twitter youtube